News

Insights on Mountain Province Diamonds Q2 2025 Production Update

Insights on Mountain Province Diamonds Q2 2025 Production Update

Mountain Province Diamonds Unveils Q2 2025 Results

Mountain Province Diamonds Inc. (TSX and OTC: MPVD) has announced its production and sales figures for the quarter ending June 30, 2025, from its Gahcho Kué Diamond Mine (GK Mine). The company reported significant insights into its operations that will shape its future endeavors, as detailed below.

Production Highlights for Q2 2025

The latest quarter saw a total recovery of 708,072 carats, which represents a 46% decrease compared to Q2 of the previous year, which had 1,318,680 carats. This reduction is noteworthy as it indicates various operational challenges faced during the quarter.

Key Production Metrics

Breaking down the production figures:

  • Average Grade: The average grade was 0.8 carats per tonne, reflecting a 41% decrease from 1.37 carats per tonne in Q2 2024.
  • Ore Tonnes Mined: A total of 134,597 ore tonnes were mined, an 86% reduction compared to the previous year’s 971,311 tonnes, with all ore treated sourced from stockpiles.
  • Total Tonnes Treated: The company treated 883,739 tonnes during this quarter, a 9% decrease from 965,984 tonnes treated in Q2 2024.

Sales Performance Overview

During Q2 2025, Mountain Province Diamonds sold 411,114 carats, generating revenue of $36.8 million (US$26.6 million). This reflects an average sale price of $90 per carat (US$65 per carat). This is in stark comparison to Q2 2024, where sales were higher at 557,361 carats and total revenue reached $56.8 million.

CEO’s Perspective on Operations

Mark Wall, President and CEO, noted the operational challenges faced during this busy time of year. He highlighted that:

  • Due to finalizing ice-road resupply at the end of Q1, considerable cold temperatures posed additional management challenges.
  • Despite these difficulties, total tonnes mined improved, with a 32% increase over the same period in 2024.
  • Mining efforts have focused on the 5034 North East Extension (NEX) orebody, which yielded improved grade but lower overall than expected.

Future Production Strategies

The processing facility has shown strong performance despite the challenges presented by low-quality stockpiles. Plans for Q3 include ramping up production from NEX, with anticipated increases of 100,000 tonnes in July, reaching up to 275,000 tonnes in September. This strategic approach aims to optimize operations and enhance production efficiency moving forward.

Key Information Regarding Earnings Release

The quarterly conference call will take place to discuss Q2 financial results on the scheduled date. Stakeholders are encouraged to engage during this session to gain insights into the future direction of Mountain Province Diamonds.

About Mountain Province Diamonds

Mountain Province Diamonds Inc. is a key player in the diamond mining sector, holding a 49% interest in the Gahcho Kué diamond mine. This joint venture exhibits substantial mineral resources surrounding the site. With extensive mineral claims, the company is focused on ongoing exploration and development opportunities.

Contact Information

For any queries or further information, please reach out to:

Mark Wall, President and CEO
151 Yonge Street, Suite 1100
Toronto, Ontario M5C 2W7
Phone: (416) 361-3562
Email: info@mountainprovince.com

Frequently Asked Questions

What were the total carats recovered in Q2 2025?

The total carats recovered were 708,072.

How has production changed compared to Q2 2024?

Production decreased by 46% from 1,318,680 carats in Q2 2024.

What was the average sale price per carat in Q2 2025?

The average sale price per carat was $90.

What is the company’s focus for Q3 2025?

The focus will be on ramping up production at the NEX orebody.

Who can be contacted for more information regarding Mountain Province Diamonds?

Mark Wall, the President and CEO, is available for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading